risperidone has been researched along with Age-Related Osteoporosis in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a cross-sectional study, consecutive premenopausal, female, DSM-IV schizophrenia patients who were treated with either risperidone (N = 12) or olanzapine (N = 14) for at least 2 years were included." | 7.72 | Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. ( Becker, D; Liver, O; Mester, R; Rapoport, M; Weiss, M; Weizman, A, 2003) |
| "In a cross-sectional study, consecutive premenopausal, female, DSM-IV schizophrenia patients who were treated with either risperidone (N = 12) or olanzapine (N = 14) for at least 2 years were included." | 3.72 | Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. ( Becker, D; Liver, O; Mester, R; Rapoport, M; Weiss, M; Weizman, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laekeman, G | 1 |
| Zwaenepoel, L | 1 |
| Reyntens, J | 1 |
| de Vos, M | 1 |
| Casteels, M | 1 |
| Valiquette, G | 1 |
| Becker, D | 1 |
| Liver, O | 1 |
| Mester, R | 1 |
| Rapoport, M | 1 |
| Weizman, A | 1 |
| Weiss, M | 1 |
| Meaney, AM | 1 |
| O'Keane, V | 1 |
4 other studies available for risperidone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Osteoporosis after combined use of a neuroleptic and antidepressants.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Drug Interactions; Female; Humans; | 2008 |
Risperidone in children with autism and serious behavioral problems.
Topics: Adolescent; Adult; Antipsychotic Agents; Autistic Disorder; Humans; Hyperprolactinemia; Hypogonadism | 2002 |
Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Benzodiazepines; Bone Density; Female; Humans; Middle Age | 2003 |
Reduced bone mineral density in patients with schizophrenia receiving prolactin raising anti-psychotic medication.
Topics: Adult; Antipsychotic Agents; Bone Density; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; O | 2003 |